Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,471 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
DENV-2 Outbreak Associated With Cosmopolitan Genotype Emergence in Western Brazilian Amazon.
Ribeiro JR, Roca TP, Cartonilho GDS, Passos-Silva AM, Moreira HM, Teixeira KS, da Silva ALF, Lugtenburg CAB, Dos Santos AO, Villalobos Salcedo JM, do Nascimento VA, de Souza VC, Roque RA, Krieger MA, Naveca FG, Rampazzo RCP, Vieira DS. Ribeiro JR, et al. Among authors: de souza vc. Bioinform Biol Insights. 2024 May 11;18:11779322241251581. doi: 10.1177/11779322241251581. eCollection 2024. Bioinform Biol Insights. 2024. PMID: 38737722 Free PMC article.
Post-mortem detection of hemoplasmas (hemotropic Mycoplasma spp.) in South American fur seal (Arctocephalus australis) sampled in Rio Grande do Sul State, southern Brazil.
de Oliveira Battisti L, Mongruel ACB, Fagundes-Moreira R, Baggio-Souza V, de Souza VK, de Amorim DB, Wagner PGC, Souza UA, Gonçalves AP, Girotto-Soares A, de Faria Valle S, André MR, Soares JF. de Oliveira Battisti L, et al. Among authors: de souza vk. Comp Immunol Microbiol Infect Dis. 2024 Apr 26;109:102187. doi: 10.1016/j.cimid.2024.102187. Online ahead of print. Comp Immunol Microbiol Infect Dis. 2024. PMID: 38703540
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.
Massari F, Santoni M, Takeshita H, Okada Y, Tapia JC, Basso U, Maruzzo M, Scagliarini S, Büttner T, Fornarini G, Myint ZW, Galli L, Souza VC, Pichler R, De Giorgi U, Gandur N, Lam ET, Gilbert D, Popovic L, Grande E, Mammone G, Berardi R, Crabb SJ, Kemp R, Molina-Cerrillo J, Freitas M, Luz M, Iacovelli R, Calabrò F, Tural D, Atzori F, Küronya Z, Chiari R, Campos S, Caffo O, Fay AP, Kucharz J, Zucali PA, Rinck JA, Zeppellini A, Bastos DA, Aurilio G, Mota A, Trindade K, Ortega C, Sade JP, Rizzo M, Fiala O, Vau N, Giannatempo P, Barillas A, Monteiro FSM, Dauster B, Mennitto A, Nogueira L, de Carvalho Fernandes R, Seront E, Aceituno LG, Grillone F, Cutuli HJ, Fernandez M, Bassanelli M, Kopp RM, Roviello G, Abahssain H, Procopio G, Milella M, Kopecky J, Martignetti A, Messina C, Caitano M, Inman E, Kanesvaran R, Herchhorn D, Santini D, Bamias A, Bisonni R, Mosca A, Morelli F, Maluf F, Soares A, Nunes F, Pinto A, Zgura A, Incorvaia L, Ansari J, Zabalza IO, Landmesser J, Rizzo A, Mollica V, Marchetti A, Rosellini M, Sorgentoni G, Battelli N, Buti S, Porta C, Bellmunt J. Massari F, et al. Among authors: souza vc. Cancer Immunol Immunother. 2024 Apr 18;73(6):106. doi: 10.1007/s00262-024-03682-w. Cancer Immunol Immunother. 2024. PMID: 38634928 Free PMC article.
1,471 results